Nike Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Nike (NKE) is scheduled to release Q1 earnings on September 30, with analysts projecting a notable decline in EPS to $0.27 from $0.70 year-ago and revenue to $11.00 billion from $11.59 billion. This comes despite Nike's consistent history of beating EPS estimates in recent quarters, and ahead of the report, multiple analysts, including TD Cowen with an upgrade to Buy, have recently raised price targets, suggesting continued underlying confidence in the stock.

Analysis

Nike, Inc. is approaching its first-quarter earnings release with significantly lowered market expectations, creating a potential inflection point for the stock. Analysts anticipate a sharp contraction in performance, with earnings per share (EPS) projected to fall to $0.27 from $0.70 in the prior-year period and revenue expected to decline to $11.00 billion from $11.59 billion. This bearish forecast, however, is juxtaposed with Nike's consistent history of outperformance, having beaten EPS estimates in eight consecutive quarters. Reflecting a nuanced view, multiple analysts have recently raised their price targets despite maintaining neutral ratings; Morgan Stanley, UBS, and Citigroup have all lifted targets to the $70-$74 range, slightly above the current price of $69.55. More notably, TD Cowen upgraded the stock from Hold to Buy, setting an optimistic price target of $85. This combination of weak fundamental projections and recent positive analyst revisions suggests that while near-term headwinds are acknowledged, some on Wall Street believe the negative outlook may be fully priced into the stock, setting a low bar for the upcoming earnings report.

Key Decisions for Investors

• Investors should consider that the sharply lowered consensus EPS estimate of $0.27 sets a low hurdle for Nike, and a beat, consistent with its track record, could serve as a significant positive catalyst.
• Monitor management's forward-looking guidance in the upcoming earnings call, as it will be more critical than the backward-looking Q1 results in determining if the recent analyst price target hikes are justified.
• Given the divergence between neutral ratings with modest price target lifts and a single outright 'Buy' upgrade to $85, investors should weigh whether the stock presents a limited upside opportunity or a more substantial value play.
• A prudent strategy may involve holding existing positions while awaiting the earnings report to validate whether the company's fundamentals are stabilizing, as hinted by the recent positive analyst sentiment.